Off-Label Yellow Fever and Hepatitis A Vaccination in Traveling ChildrenBrief Report Published on 2024-03-212024-09-05 Journal: Children [Category] update2024, [키워드] adverse effects hepatitis A off-label Vaccine yellow fever [DOI] 10.3390/children11030374 PMC 바로가기 [Article Type] Brief Report
COVID-19 and MIS-C treatment in children—results from an international surveyarticle Published on 2023-09-062024-09-05 Journal: European Journal of Pediatrics [Category] update2024, [키워드] antivirals children COVID-19 global access monoclonal antibodies off-label [DOI] 10.1007/s00431-023-05179-7 PMC 바로가기 [Article Type] article
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance dataArticle Published on 2022-12-012023-07-09 Journal: Fundamental & clinical pharmacology [Category] COVID19(2023년), [키워드] benefit-risk balance COVID-19 Hydroxychloroquine off-label Safety [DOI] 10.1111/fcp.12797 PMC 바로가기
Current evidence on the use of anakinra in COVID-19Review article Published on 2022-10-012022-10-05 Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 바이오마커, 임상, 진단, 치료제, [키워드] acute respiratory distress syndrome administration Anakinra approval clinical evidence clinical status COVID-19 COVID-19 patient COVID-19 patients current cytokine cytokine release Cytokine release syndrome Cytokine storm dose early stage effective Evidence IL-1 IL-1 receptor antagonist Immunomodulatory agent include inhibit interleukin-1 intravenous knowledge management mechanical ventilation multiple organ failure off-label Prevent progression Remdesivir required secondary hemophagocytic lymphohistiocytosis shown syndrome the disease the SARS-CoV-2 therapeutic effect therapeutic effects therapy Treatment treatment approach viral replication [DOI] 10.1016/j.intimp.2022.109075 [Article Type] Review article
Current status of antihistamine drugs repurposing for infectious diseasesReview article Published on 2022-09-012022-10-05 Journal: Medicine in Drug Discovery [Category] 신약개발, [키워드] active against Anti-infective Antihistamines applicability article Blood brain barrier Candida carried Chemical library clinical trial clinical trials cross current determine dose drug Ebola virus Efficacy English eventual need FIVE Google Scholar Government groups growth Health hepatitis C IC50 identify in vitro activity in vitro data in vivo Infectious disease information inhibited intrinsically lack Leishmania objective off-label Pathogens pharmacological Plasmodium repurposing Research Result rodents Side effects Staphylococcus aureus Staphylococcus epidermidis Support suppressed Trial Trypanosoma virus [DOI] 10.1016/j.medidd.2022.100140 [Article Type] Review article
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox OutbreakArticle Published on 2022-08-252022-11-15 Journal: Viruses [Category] Fulltext, 원숭이두창, 진단, 치료제, [키워드] animal antivirals approved benefit Canada clinical study COVID-19 development disease dosage drug drug combination drug resistance Efficacy EMA European Medicines Agency food forms Health Canada highlight infections injection Interaction literature literature review Monkeypox MOST non-human primate off-label orthopoxvirus outbreak parameters Patent patents. pharmacokinetic regulatory agency rule SIGA-246 technology tecovirimat TPOXX treat Treatment United State USA Viral diseases website [DOI] 10.3390/v14091870 PMC 바로가기
Treatment strategies of COVID-19: A rheumatology perspectiveCOVID-19의 치료 전략: 류마티스학적 관점Review Published on 2022-08-012022-09-12 Journal: European journal of internal medicine [Category] COVID19(2023년), SARS, 진단, 치료법, 치료제, [키워드] absence acute respiratory syndrome adaptive approved authority Colchicine Coronavirus-2 Corticosteroid COVID-19 Critical Critically ill patient Dexamethasone DMARDs effective host cell Immunity Inflammatory response inhibitors interleukin-6 janus Kinase inhibitor mAbs monoclonal antibody off-label Perspective plethora progression Proinflammatory cytokine Remdesivir Replication rheumatologist rheumatology SARS-CoV-2 SARS-CoV-2 mAbs. SARS-CoV-2 pneumonia therapeutic strategy Treatment viral entry [DOI] 10.1016/j.ejim.2022.05.014 PMC 바로가기 [Article Type] Review
Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implicationsSARS-2-CoV-2019(COVID-19) 감염 치료에 사용되는 약물의 신경정신병적 발현 및 그 관리: 개요 및 실행 의미Review Published on 2022-07-012022-09-11 Journal: Asian journal of psychiatry [Category] COVID19(2023년), SARS, 변종, 치료법, 치료제, [키워드] Adverse adverse effect Adverse reaction Affect Anti-COVID-19 medications complicate complications consequence COVID COVID-19 COVID-19 treatment dose drug drug-drug interaction drugs hcp Healthcare professional healthcare professionals help highlight implication Infection lAbel management manifestation medication medications myriad Neuropsychiatric off-label off-label use physical Primary infection Prognosis review risk factor Risk factors SARS-2-CoV-2019. Symptom Symptoms Topic Treatment treatment guideline treatment guidelines variant virulence virus [DOI] 10.1016/j.ajp.2022.103101 PMC 바로가기 [Article Type] Review
More questions than answers for the use of inhaled nitric oxide in COVID-19Review article Published on 2022-07-012022-10-05 Journal: Nitric oxide : biology and chemistry [Category] 바이오마커, 임상, 치료제, [키워드] acute respiratory distress administration anti-inflammatory actions antiviral properties approved ARDS bloodstream clinical outcomes Cohort studies coronavirus disease COVID-19 Factor Hypoxemia IMPROVE improvements in oxygenation inactivation Inhaled lung mechanisms Neonates nitric oxide off-label Oxygenation pathological conditions patient selection patients with COVID-19 Potential treatment pulmonary hypertension question Randomized Randomized controlled trial Respiratory failure retrospective SARS-CoV-2 syndrome systemic effect therapy translated Treatment variety Vascular Ventilated [DOI] 10.1016/j.niox.2022.05.001 [Article Type] Review article
Pregnancy and COVID-19, focus on vaccine and pharmacological treatment임신과 코로나19, 백신과 약리치료에 집중Review Published on 2022-06-012022-09-11 Journal: Journal of reproductive immunology [Category] 변종, 임상, 치료법, 치료제, [키워드] change clinical clinical evidence clinical trials Comorbidities compassionate use Complication complications COVID-19 COVID-19 disease COVID-19 mRNA vaccine COVID-19 mRNA vaccines drug treatments drugs during pregnancy Evidence excluded global pandemic group highlighting immune increased risk indicate individual Infants Infection knowledge limit mother off-label pharmacological treatment population groups Pregnancy pregnancy complications pregnant women progression recommendation Respiratory system Spread therapy vaccination Vaccine variant variants virus women [DOI] 10.1016/j.jri.2022.103630 PMC 바로가기 [Article Type] Review